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Background: Due to the rapid increase in healthcare costs of low back pain (LBP), it is 
important to provide clinically and cost effective interventions to individuals with the condition. 
Objective: To evaluate all recent economic evaluations of physiotherapy interventions for 
patients with LBP.  
Data sources: Searches were undertaken on CINAHL, Medline, the National Health Service 
Economic Evaluation database (NHSEED), Health Technology Assessment (HTA), and 
Database of Abstracts of Review of Effects (DARE) from January 2008 to October 2018.                                            
Study selection: Randomised controlled trials, cohort studies that assessed the cost- 
effectiveness of physiotherapy interventions on patients with LBP compared to a control group. 
A Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist was 
used to assess the quality of the included studies. 
Data extraction/Data synthesis: Pairs of review authors independently extracted data. A 
descriptive synthesis was conducted to summarise the data.  
Results: A total of 1,531 articles were identified, and 11 studies fulfilled the inclusion criteria. 
The total number of participants included in the studies included in the review were 2,633 and 
their age ranged from 18 to 80 years. In the included studies, the duration of LBP ranged from 
3 weeks to 1 year. Except in one study, all the included studies reported that physiotherapy 
intervention was cost effective compared to controls. Because of the heterogeneity of the 
included studies, meta-analysis was not possible. 
Conclusion: Although most of the included studies suggested that physiotherapy 
interventions were cost effective, it is difficult to pool their cost effectiveness for a conclusive 
evidence.      
Systematic review registration number CRD: 42018089773. 
 



















Low-back pain (LBP) remains a global health problem, affecting most adults at some point 
during their lifetime [1]. Despite the variations among LBP epidemiological studies, those from 
developed countries showed that the lifetime, 1-year and a point prevalence of LBP ranges 
between 60% to 80%, > 50%, and 15% to 30%, respectively [2]. Compared to the general 
population of high-income countries, the prevalence or incidence of LBP is 2 – 4 times higher 
than the population of rural low-income countries [3]. Parallel to this, the estimate of the 1-
year incidence of any episode of LBP ranged between 1.5% and 36% [1]. ]. LBP was 
responsible for around 60.1 million years lived with disability for all age groups globally in 
2015, and there will be an overall increase in its global burden due to population increase and 
ageing [4]. Although health care for patients with LBP varies with providers offering therapies, 
the mean direct and indirect costs of LBP care are approximately twice as high for patients 
with chronic LBP compared to acutely ill patients [5]. In the United States alone the economic 
loss due to the condition has been estimated to be between US$100 to US$200 billion every 
year [6, 7]. The indirect costs of LBP account for more than 52% to 54% of its total cost. Also, 
approximately 25% of the direct costs of LBP are ascribed to physiotherapy interventions and 
rehabilitation [5]. Overall, LBP is one of the leading causes of high health care costs 
particularly in industrialised countries. 
What is already known on this topic: Interventions such as interdisciplinary rehabilitation, exercise, 
acupuncture, spinal manipulation, and cognitive behavioural therapy were shown to be cost-effective 
for patients with chronic LBP. As new physiotherapy interventions for LBP continue to emerge, it is 
important to examine the cost-effectiveness of these interventions. 
What this review adds: Physiotherapy interventions such as advice on self-management, a novel 
motion sensor biofeedback treatment, individualised physical therapy plus advice and a brief telephone 
advice were shown cost-effective for LBP from health-care or societal perspective. Ten individual 
sessions and 20 group sessions which include exercise and behavioural principles were unlikely to be 






The National Institute for Health and Care Excellence (NICE) guideline on the management 
of LBP comprises a range of different interventions including physiotherapy interventions and 
medications [8]. Physiotherapy interventions such as advice and information, exercise 
programmes, and psychological therapies using cognitive behavioural approach are the 
mainstay management strategies for LBP. Evidence from randomised controlled trials 
demonstrated that physiotherapy interventions such as exercise therapy, behavioural and 
multidisciplinary interventions are effective in reducing pain intensity and disability [9,10]. 
However, as stated above, due to the nature of the condition its management is resource 
intensive.  
Given the range of treatments or interventions for the management of LBP, it is important to 
consider the economic costs of physiotherapy interventions in allocating healthcare resources. 
Economic evaluations are tools that compare effects and costs of interventions with an 
alternative strategy from healthcare system, patient and societal perspective [11]. A 
healthcare system perspective is a point of view adopted when deciding to include treatment 
costs such as medical, non-medical costs associated with managing the disease such as costs 
of staff time, hospital admissions, and costs of managing adverse events caused by treatment 
in economic evaluation [11]. Whereas the adoption of societal perspective reflects a full range 
of social opportunity costs including, for example, the productivity losses arising from patients’ 
inability to work [12]. Moreover, the diagnosis of LBP and subsequent related care including 
visits to physicians, medication, surgery and related treatments may also impose a financial 
burden specifically to patients and their families.  
Economic evaluation as a tool, for example, aims to improve the efficiency of healthcare 
resources in relation to physiotherapy interventions [13]. In previous reviews [6], a guideline 
endorsing treatments of interdisciplinary rehabilitation, exercise, acupuncture, spinal 
manipulation, and cognitive behavioural therapy was shown to be cost-effective for patients 
with chronic LBP [14]. However, there is inconsistency and lack of evidence on the cost-
effectiveness of some physiotherapy interventions including advisory consultation, 
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medications, massage and yoga or relaxation. In addition, the review is outdated as this was 
carried out over 10 years ago. As new physiotherapy interventions for LBP continue to 
emerge, it is important to examine the cost-effectiveness of these interventions. The purpose 
of the current review was to evaluate all recent economic evaluation studies of physiotherapy 
interventions for LBP. 
Methods  
Study Registration 
This systematic review was conducted in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) statement [15].The systematic review was 
registered on PROSPERO database (International Prospective Register of Systematic 
Reviews), with registration number CRD: 42018089773.  
Information Sources and Search 
A literature search using Cumulative Index to Nursing and Allied Health Literature (CINAHL); 
MEDLINE; Database of Abstracts of Reviews of Effects (DARE); Health Technology 
Assessment (HTA); and the Centre for Reviews and Dissemination (CRD) databases was 
carried out from January 2008 to October 2018. The search terms used were back pain, low 
back pain, physiotherapy, health economics, economic evaluation, cost benefit analysis, cost 
effectiveness analysis, cost utility analysis, cost, expenditure, value, and money. These 
search terms were combined using conjunctions words such as ‘OR’ and ‘AND’. A systematic 
hand searching of citations referenced in articles and existing reviews was part of the overall 
search strategy. Two reviewers were independently involved in the literature search and any 
discrepancies were resolved by consensus or consultation with a third reviewer. 
Eligibility Criteria 
The criteria used for inclusion of studies were those that reported the effectiveness and cost 
of physiotherapy interventions provided by a physiotherapist; had abstracts published in 
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English; involved patients with LBP above the age of 18 years; and conducted in any 
geographical location. Systematic reviews, narrative literature reviews, conference papers, 
abstract and studies not yet fully completed were excluded.  
Study Selection and Quality Assessment 
Two researchers TG and FF were independently involved in the study selection and quality 
assessment. Any disagreement between the two review authors was resolved through 
discussion with a third reviewer (JMW). Title and abstracts that did not provide enough 
information regarding the eligibility criteria were considered for full-text evaluation and 
assessed if they met the inclusion criteria. Methodological quality of the included studies was 
assessed using the criteria listed in the Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS) statement [16]. Twenty-four items were addressed in six categories, 
which include title and abstract, introduction, methods, results, discussion, and others. Studies 
were labelled positive (√) if they reported in full, and negative (x) if they did not fulfil the listed 
criteria in the CHEERS statement. Those studies that had partial or inconclusive information 
were labelled as partial (P). A total score of 1 was assigned if they fulfilled the requirement of 
reporting for that Item completely, 0 for not reporting and 0.5 for partial reporting. The 
maximum score for an article that reported all information was 24, and cut-off point of score 
75% was considered to assess the quality of the included studies by the researchers. Studies 
were determined to be of ‘good quality’ studies if they scored ≥ 75%; whereas studies were 
determined ‘poor quality’ studies if they scored < 75%. The total scores of the CHEERS 
statement are presented in a table.  
Data Extraction  
Two reviewers independently conducted the data extraction and resolved discrepancies by 
consensus or consultation with a third reviewer. The following characteristics of the studies 
were extracted: author, year of publication, number of participants, age, location, setting, 
duration of pain, type of interventions, comparator, outcome measures, primary and 
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secondary outcomes, time horizon, and costs, type and perspective of the economic 
evaluation, and study results.  
Data Analysis 
A descriptive synthesis was conducted to summarise the extracted results. No meta-analysis 
was carried out due to heterogeneity of the methodologies used for cost-effectiveness analysis 
of the included studies. In addition, many studies included in this systematic review did not 
report standard deviation of the mean effects and costs, thus preventing statistical pooling.  
Results 
Description of the Studies 
The literature search identified 1,531 potential articles, of which 1,471 were found irrelevant 
after screening the titles and abstracts (Figure 1). The remaining 13 articles were assessed 
for inclusion by reading the full-text articles, and 11 of them were found eligible and were 
included for data synthesis.    
                             ------------------Figure 1 about here-----------------          
The scores of the methodological quality assessment based on the CHEERS criteria checklist 
are presented in Table 1. Five studies [20, 23, 24, 27, 28] achieved more than 75% of the 
CHEERs statement checklist criteria. The remaining six studies [18, 19, 21, 22, 25, 26] scored 
less than 75% of the criteria. All of the included studies contained the details of patient 
demographics, interventions, and comparator.  
                       -------------Table 1 about here------------- 
One of the included studies reported a cost-effectiveness of physiotherapy intervention on a 
population of pregnancy related LBP [19]. The remaining studies were targeted at employed 
and unemployed populations with specific or nonspecific LBP. The mean age of the 
populations within the studies ranged from 18 to 80 years, and duration of pain ranged from 
three weeks to 1 year. The geographical locations reported in the studies were Australia (n = 
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2), Brazil (n = 2), Canada (n = 1), Netherlands (n = 3), Israel (n = 1) Norway (n = 1), and United 
Kingdom (n = 1).  
Economic Evaluation 
The designs of the included economic evaluation studies were cost-effectiveness analysis 
(CEA) (n = 1) [19], cost-utility analysis (CUA) (n = 2) [20, 21] CEA and CUA (n = 7) [18, 23,22, 
25, 27, 28, 26] and CUA, CEA and cost-benefit analysis (n = 1) [24]. The components of 
economic evaluation within the studies included were interventions, comparator, effects, 
costs, and results. The analysis of these components are outlined below. 
Resources Used and Cost 
The resources used and costs of the interventions and control varied according to the 
perspective adopted for the analysis. More than 70% of the included studies used a societal 
perspective [18, 19, 20, 22, 23, 24, 25, 28], and the remaining studies adopted the healthcare 
system perspective. The key resources used to assess the costs of physiotherapy 
interventions were medications (n = 11), consultation/advice (n = 11), hospitalisation (n = 3), 
and absenteeism from work (n = 8). 
The costs of the interventions were valued using dollars ($), euro (€), pound sterling (£), and 
new shekel (NIS). Seven of the studies included estimated the costs of the interventions 
greater than the control arm. In all the included studies, the costs were estimated over a period 
of 12 months. The highest total mean of health-care cost (£421.52) per person in the 
intervention arm was reported in Norway [26]. Whereas, the lowest mean cost (£68.45) per 
patient was reported in the Netherlands [19]. The remaining four studies had lower cost 
estimate in the intervention arm than the control arm. For example, the mean costs (-$614 CI 
-$3133 to $255) of the intervention arm, include a brief telephone advice, a clinical consultation 
with a physiotherapist, and referral to a 6-month telephone-based health coaching per person 
was less than the control arm [28].  
Effectiveness Measure and Outcomes 
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Pain intensity, general perceived effect, patient physical and mental function, fear of 
movement, disability, and health related quality of life were used to assess the health status 
of patients with LBP. Nine of the studies included reported the effects of physiotherapy 
interventions on patient disability and pain intensity; these were measured using the Roland-
Morris LBP and Disability Questionnaire (RMDQ) and 11-point scale, respectively 
[23,20,22,19,25, 26, 27, 28, 18]. All the included studies reported that health related quality of 
life improved following physiotherapy interventions. However, two studies reported that the 
mean effectiveness of physiotherapy interventions was not significantly different compared to 
the control arm [19, 28]. For example, no difference was observed in quality adjusted life years 
(QALYs), disability, pain, body mass index (BMI) and weight between patients who received 
lifestyle intervention and usual are as control [28]. However, any small improvement of 
effectiveness from the intervention arm should always be compared to its increment of costs 
as this may affect the overall cost- effectiveness of the interventions.   
Cost-effectiveness of Physiotherapy Interventions 
All the studies included reported incremental cost effectiveness ratios (ICER) in terms of either 
cost/QALYs gained  or cost per patient outcomes such as functional status, pain intensity, and 
disability (Table 2). All the included studies reported ICER in favour of physiotherapy 
intervention. One study [18] reported that physiotherapy intervention was not cost-effective; in 
this case the costs of physiotherapy intervention were similar to the control arm. 
                             ------------Table 2 about here------------                       
Discussion 
The aim of this review was to examine the cost-effectiveness of physiotherapy interventions 
for LBP by synthesising information from recent cost-effectiveness studies. Our systematic 
review assessed 15 full-texted articles, and out of which 11 fulfilled the inclusion criteria. This 
is the first systematic review to examine the cost-effectiveness of physiotherapy interventions 
for LBP using CHEERS statement to evaluate the quality of studies included, all of which 
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scored above 50%. The included studies were conducted in Australia, Brazil, Canada, 
Netherlands, Norway, Israel and United Kingdom. The types of economic evaluation used in 
the included studies were CEA (n = 2), CUA (n = 2), CEA and CUA (n = 6), and CUA, CEA 
and cost-benefit analysis (n = 1), and the analysis was conducted over a period of six and 
twelve months. The perspectives adopted in the included studies were either societal or 
healthcare. 
The key resources used to assess the costs of the physiotherapy interventions were 
medications, consultation/advice, hospitalization, and absenteeism from work. All the included 
studies reported that LBP patients improved their pain intensity, functional status, health 
related quality of life and disability with the physiotherapy interventions. However, two studies 
reported that the mean outcome measures such as health related quality of life, pain, disability, 
weight and body mass index of physiotherapy interventions were not significantly different 
compared to the control arm. Most of the studies included in the review also reported that the 
ICER was in favour of physiotherapy interventions; for example, physiotherapy interventions 
such as advice on self-management by physiotherapist, a novel motion sensor biofeedback 
treatment plus guidance-based care, individualised physical therapy plus advice, a brief 
telephone advice, physical activity in conjunction with physiotherapy, and cognitive based 
education programme were shown to be cost-effective for LBP either from the health-care or 
societal perspective. However, it is worth noting due to the variation of studies included such 
as the healthcare system, location, patient follow up, and the perspectives adopted, it is 
difficult to generalise the cost-effectiveness of physiotherapy interventions. In addition, the 
heterogeneity of the population included in the studies such as acute/chronic LBP, 
specific/non-specific LBP and pregnancy related LBP might make generalising the findings of 
the cost-effectiveness of physiotherapy interventions difficult.  
Our findings were compared to those of previous review of cost-effectiveness physiotherapy 
interventions or treatments for low back pain [14]. Parallel to the findings of the current review, 
previous literature found evidence to support that interdisciplinary rehabilitation, exercise, 
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acupuncture, spinal manipulation, and cognitive behavioural therapy were cost-effective in 
patients with LBP. They also highlighted that there was insufficient and no evidence on the 
cost-effectiveness of advice and medications in the management of LBP. Due to the short 
time horizon used in the studies included in the present review it is difficult to determine the 
long-term costs and benefits of physiotherapy interventions. In addition, in the current review 
there was no evidence of cost-effectiveness of physiotherapy interventions from patient and/or 
caregivers perspective. Thus, it is important that the cost-effectiveness of the various forms of 
physiotherapy interventions are considered and conducted from the patient and caregivers 
perspective.  
One of the major strengths of the current review was the use of an established quality 
assessment tool for the included studies. The application of the CHEERs checklist on the 
included studies showed poor reporting standard; for example, the majority of the included 
studies did not report the method used to estimate costs and sensitivity analysis. The 
uncertainty surrounding the results of cost-effectiveness analysis should be included in health 
economic studies [29]. Secondly, the conclusions are based on recent economic evaluations 
of physiotherapy interventions up to October 2018.  
On the other hand, the conclusions of this review should be viewed with caution. To date there 
are many peer reviewed published studies showing that physiotherapy interventions are cost-
effective for LBP; however, it is difficult to perform meta-analysis within this published 
literature. The main reason for this is that there was no uniformity of analysis on the costs and 
effects of the interventions within the cost effectiveness studies. For example, the resources 
used for the interventions were different across studies. In addition, there was no evidence on 
the long-term costs and effects of physiotherapy interventions. Thus, more studies examining 
the long-term clinical and cost-effectiveness of physiotherapy interventions in patients with 
LBP are needed. Moreover, more economic analysis examining physiotherapy interventions 
in real-world settings are required. This is because, patients with LBP in real world settings 
may receive multiple interventions simultaneously. Data on costs of physiotherapy 
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interventions in the individual studies included in this review might have changed. This means, 
the use of new data specifically on cost may change the cost-effectiveness of physiotherapy 
interventions. Lastly, there may be English language bias in this review as only studies 
published in English language were included. It is understood that cost-effectiveness studies 
may be highly influenced by the geographical locations where they are conducted, because, 
decision makers wanted them to be reported in their home language.  
 Overall, due to the above limitations, this systematic review has limited data synthesis, limited 
ability to generalise and compare the cost-effectiveness of physiotherapy interventions. It is 
difficult to provide a conclusive evidence. Future studies that compare directly the cost-
effectiveness of two different clinically effective physiotherapy interventions or different doses 
within the same population would be helpful to evaluate the cost-effectiveness of 
physiotherapy interventions. Furthermore, to increase their relevance to decision makers and 
commissioners, future cost effectiveness analysis studies should provide the method used to 
measure healthcare resource use and costs, and sensitivity analysis. 
Conclusion 
The purpose of this review was to evaluate all recent economic evaluations of physiotherapy 
interventions. Our findings indicated that there was evidence to support that physiotherapy 
interventions were cost-effective; however, the cost-effectiveness of physiotherapy 
interventions was highly dependent on the type of intervention used in the control arm. The 
interventions used in the control arm within the current review included current physiotherapy 
guidelines or no-interventions. The presence of this kind of variation within the included studies 
has become a drawback not to pool the results of the cost-effectiveness studies. As a result, 
it is not possible to generalise the findings of cost-effectiveness of physiotherapy interventions. 
However, our findings may be important to clinicians and decision makers as they may help 
to improve the outcomes of physiotherapy for patients with LBP. Future cost-effectiveness 
studies are needed to examine the cost-effectiveness of physiotherapy interventions within 
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homogenous populations and studies that consider cost-effectiveness from the patient and 
caregiver perspective.  
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Figure 1. The preferred reporting for systematic review diagram representing the systematic 
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Table 1: Methodological quality assessment of studies using the CHEERs statement 
Study Score (/24) 
Van der Roer 2008 [18] 16.5 
Bastiaenen 2008 [19] 17 
Haines 2017 [20] 19 
Hahne 2017 [21] 16 
Werner 2016 [22] 16 
Miyamoto 2018 [23] 19 
Lambeek 2010 [24] 18 
Herman 2008 [25] 16.5 
Lamb 2010 [26] 14 
Canaway 2018 [27] 18 






















Intervention Control Outcomes/ 
Measurement used  
Type of cost/ 
Perspective 
Costs (per participant)/ 
Effectiveness/ ICER 
Van der Roer 2008 
[18],  
Netherlands/  





#114 (18 to 65 
years) with 
chronic 
nonspecific LBP.                                                     
Pain duration > 
12 weeks.                                                                  
Ten individual sessions and 
20 group sessions. These 
training sessions were 
provided by a
physiotherapist. It include 
exercise and behavioural
principles.  
Usual care  Pain intensity score/11-
Point numerical scale                                       
General perceived 
effect/6-Point scale                                                  
Patients functional 
status/RMDQ                                                               
Quality of life/Euro-Qol 





€233 [95% CI -2185; 2764] higher for Int.                                                                                                                                                                                                                                                                                 
Effectiveness 
Int. gained 0.06 points [95% CI:−2.22; 2.34] for function; 
−1.02 points [95% CI:−2.14; 0.09] pain intensity and 0.03 
[95% CI−0.06; - 0.12] QALYs.  
 ICER                                                        
 € 5141/QALY gained.  
 Int. not cost- effective 
Bastiaenen 2008 
[19], 





#126 women         
(> 18 years) with  
non -specific 
pregnancy 
related LBP (3 
weeks after 
delivery) 
Advice on self-management 
by a physiotherapist (a brief 





Physical and mental 
function / RMDQ                                                    
Global Perceived effect/       
7-Point scale;                  
Pain intensity/VAS                                           
Fear of 
movement/Tempa scale                                    
Health status/SF - 36 





€-4341 [95% CI -8850;167] higher for Int.                                                                                                                                                        
Effectiveness 
RDQ* = -1.6 [-2.9; -0.5]; IPAα  = = -1 [-1.9; -1.1];       
TSK** = -2.4 [-3.8; -1.1] gained for Int.                                                                                                                                         
ICER                                                                                                                                                                                   
Both effectiveness and costs were in favour of the 
intervention. 
Int. cost- effective 







(18 to 65 years) 
with non-specific 
LBP.  
Pain duration at 
least 3 weeks.  
A novel motion-sensor 
biofeedback treatment plus 
guidelines-based care. The 
intervention was provided by 








Fear of movement/Fear 
avoidance belief 
questionnaire                                    
Pain intensity/Quadruple 
VAS                                          
Disability/RMDQ                                                                     







$477 higher medical and therapy for Int.                                                                                                                          
$-53 lower use of non-trial medical and therapy for Int.  
$-5123 higher improvement in productivity for Int.                                                                                                                                    
Effectiveness  
Favoured the intervention.                                                                                                                                                                                                                       
ICER 
Not reported 
Int. cost- effective 









Pain duration at 
least 6 weeks. 
Individual assessment for up 
to 1.5 hour duration, and six 
sessions of group therapy up 
to 1.5 hour duration each 
plus advice. Intervention 
provided by a 
physiotherapist.                      
Active 
management 
advice for a 15 
minute session. 
Back pain 
disability/RMDQ                                
Mental and physical 





£170.7 higher for Int.                                                                                                                                                                                                                    
Effectiveness 
0.099 QALY gained for Int. 
ICER 
£1,786/QALY gained.  
Int. Cost- effective                                                       
*Change in limitations in activities (RDQ); α Impact on participation and autonomy; **Pain related fear; Roland Morris Disability Questionnaire= RMDQ; CUA = Cost utility 
analysis; CEA = Cost effectiveness analysis; QALY = Quality adjusted life years; CBA = Cost benefit analysis; Qol = Quality of life; Incremental cost-effectiveness ratio = ICER; 




Table 2 (Cont.): Description of studies on the cost-effectiveness of physiotherapy interventions for the management of LBP 
Study/Location/ 




     Intervention         Control Outcomes/ 
Measurement used  
Type of cost/ 
Perspective 
Cost (per participant)/ 
Effectiveness/ ICER  
Canaway 2018 











A model of behaviour change 
aimed to increase the 
adherence and 
implementation of physical 
activity in conjunction with 
physiotherapy. Intervention 






back school, electrical 
stimulation)
Short Form Survey (SF-
12) / Euro-Qol    
                            
Disability / RMDQᵅ  
Direct cost/ 
 
Healthcare   
Costs 
NIS230 [95% CI NIS85; NIS375] higher for Int. 
Effectiveness 
Intervention arm increased from 0.66 to 0.79 (utility).        
Control improved from o.62 to 0.74 (utility) 
Intervention arm improved from 9.95 to 3.27 (RMDQ) 
Control arm improved from 10.24 to 5.97 (RMDQ) 
ICER                                                                                                                                                                                                                                            
Not reported 
Int. cost- effective  
Hahne 2017 [21], 
Australia/ CUA/ 1-
Year 




6 weeks to 6 
months. 
Individualized physical therapy 
plus advice (10 x 30 minute 
advice sessions over ten-
weeks period) and was 
delivered by a physiotherapist.                                                             
Guideline-based 
advice alone (2 X 30-
minute advice 
sessions over a 10 
weeks period)
Health related quality of 
life / Euro - Qol 




$27 [95% CI:-200; 254] higher for Int.                                                                                                                                                                                                
Effectiveness: 
0.06 [95% CI: 0.02; 0.10] QALY gained for Int. 
ICER                                                                                                                                                                                                                                                                                                                                                                             
$422 per QALY gained  
Int. cost- effective   
 









4 weeks to 1 
year. 
Cognitive- based education 
program provided by general 
practitioner and a 
physiotherapist. 
Patients were meant 
to meet with their 
provider for four 30-
minute one-to-one 
sessions during a 4-
week period.                     
Physical and mental 
function/RMDQᵅ                                             
Back pain intensity/ 11-
Point numerical scale                                                                          







$79 higher for Int.                                                             
Effectiveness 
RMDQᵅ points = 0.7 [95% CI -0.6; 1.9] higher for Int.  
0.01 [0.02; 0.03] QALY gained from Cot 
ICER                                                                                                                                                         
Not reported 
Int. cost- effective                                                                                                                                               
Herman 2008 
[25],Canada/ CEA 
& CUA/ 1-Year 
#70 (18 to 65 
years) with 
LBP. Pain 
duration of at 
least 6 weeks.  
Naturopathic care: 
acupuncture, exercise and 
dietary advice, relaxation 
training, and back care 
educational booklet. 
Intervention delivered by a 
physiotherapist.                                         
Standardized 
physiotherapy advice 
and the back care 
educational booklet 
Health related quality of 
life/ RMDQᵅ, Oswestry 
Disability Index (ODI); 






$1212 lower for Int.  
Outcome 
0.03 [95% CI: 0.01; 0.04] QALY gained for Int. 
ICER 
Not reported 
Int. cost- effective 
ᵅ Roland Morris Disability Questionnaire; CUA = Cost utility analysis; CEA = Cost effectiveness analysis; CBA = Cost benefit analysis; VAS = Visual analogue scale; Qol = 












Intervention Control Outcomes/ 
Measurement used 
Type of cost/ 
Perspective 
Costs (per participant)/ 
Effectiveness/ ICER 
Miyamoto 2018 
[23], Brazil/ CUA 














Pilates group (PG):Individual 
exercise including ground 
exercises and apparatus exercise 
was delivered by a 
physiotherapist. Pilates group 1 
(PG1)- received treatments once 
a week (6 treatment sessions); 
Pilates group 2 (PG2)- twice a 
week (12 treatment sessions); 
Pilates group 3 (PG3)-three times 
a week  (18 treatment sessions).    
Booklet group (BG): 
contained  
recommendations 
related to posture 
and movement of 
activities of a daily 
living, information on 
LBP and anatomy of 














Costs per patient were £0.3 for BG, £171 for PG1, £331 for PG2 
and £469 for PG3. 
Effectiveness 
Pain intensity, PG1, MD = −1.2, [95%CI −2.2 to −0.3] higher from 
BG; PG2, MD= −2.3 [95%-3.2 to -1.4] higher from BG; and PG3, 
MD = -2.1 [95%CI −3.0 to −1.1] higher from BG. 
Disability, PG1, MD = −1.9, [95%CI −3.6 to −0.1] higher from BG; 
PG2, MD = −4.7 [95% CI −6.4 to −3.0] higher from BG; PG3, MD 
=  −3.3, [95%CI −5.0 to −1.6] higher from BG.  
ICER                                                                                                                                                                                                                                                                                                                                                                                    
Not reported 
PG3 cost-effective.   
Williams 2019  
[28], Australia/ 












or obese.  
Pain 
duration > 3 
months. 
A brief telephone advice, a 
clinical consultation with a 
physiotherapist, and referral to a 
6-month telephone-based health 
coaching.                      
No restrictions were 
placed upon 
participant’s use of 
other health services 




quality life/SF-12                                                                
Pain intensity/0 to 10 
Point numerical 
rating scale (NRS),                                                    









$292 higher for Int.                                                                      
Effectiveness 
0.02 QALY gained for Int. 
ICER





CEA & CUA, 
CBA/ 1-Year 
 






Graded activity (GA) which is a 
time contingent programme 
based on cognitive behavioural 
principles and work place 
intervention. Intervention 
delivered by a physiotherapist, 
medical specialist and clinical 
occupational physician.  
Advice provided by 
general practitioners 
and occupational 
physicians based on 
the Dutch guideline. 
Duration until 
sustainable return to 
work/Sick leave due 
to low back pain in 
calendar days               
Health related 
quality of life/ Euro 






£5310.0 lower from Cot. 
Effectiveness  
0.09 QALY gained for Int. 
ICER                                      
-61000.0 / QALY gained.                                                                                                                                                                                                                                        
Int. cost-effective  
ᵅ Roland Morris Disability Questionnaire; CUA = Cost Utility Analysis; CEA = Cost Effectiveness Analysis; CBA = Cost Benefit Analysis; MD = Mean difference; Qol = Quality 




Table 1: Search terms used in the databases  
Search ID#     Search Terms  
S15  S3 AND S13 AND S14   
S14  
S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S11 OR 
S12   
S13  S1 OR S2   
S12  Money   
S11  Value   
S10  Expend*   
S9  Cost   
S8  Cost utility analysis   
S7  Cost effective analysis   
S6  Cost benefit analysis   
S5  Economic evaluation   
S4  Health economics   
S3  Phys*   
S2  Back pain   
S1  low back pain  
 
